Last reviewed · How we verify

NCT04039009

Apical Pelvic Support in Infertility Patients

Status unknown Last updated 2 August 2019
What this trial tests

trial testing Pelvic Organ Prolapse Quantification system in Infertility, Female in 1,100 participants. Status unknown.

Timeline
1 January 2019
Primary endpoint
30 September 2019
31 October 2019

Quick facts

Lead sponsorUludag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,100
Start date1 January 2019
Primary completion30 September 2019
Estimated completion31 October 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uludag University

Who can join

Adults 18 to 45, female only, with Infertility, Female or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate apical pelvic compartment support in infertility patients at the time of hysteroscopy. Apical pelvic compartment evaluation for pelvic organ prolapse will be performed in infertility patients undergoing hysteroscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other Uludag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04039009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing